G. F. Hoffmann

1.8k total citations
36 papers, 960 citations indexed

About

G. F. Hoffmann is a scholar working on Clinical Biochemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, G. F. Hoffmann has authored 36 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Clinical Biochemistry, 17 papers in Molecular Biology and 6 papers in Biochemistry. Recurrent topics in G. F. Hoffmann's work include Metabolism and Genetic Disorders (20 papers), Biochemical and Molecular Research (10 papers) and Amino Acid Enzymes and Metabolism (6 papers). G. F. Hoffmann is often cited by papers focused on Metabolism and Genetic Disorders (20 papers), Biochemical and Molecular Research (10 papers) and Amino Acid Enzymes and Metabolism (6 papers). G. F. Hoffmann collaborates with scholars based in Germany, United States and Netherlands. G. F. Hoffmann's co-authors include Johannes Zschocke, Abdülbari Bener, Ania C. Muntau, M. Durán, E. Christensen, Andrea Superti‐Furga, W. Lehnert, J. Leonard, A Burlina and Ardeshir A. Monavari and has published in prestigious journals such as Neurology, Nephrology Dialysis Transplantation and European Journal of Clinical Nutrition.

In The Last Decade

G. F. Hoffmann

34 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. F. Hoffmann Germany 17 561 454 114 113 100 36 960
Hilary Vallance Canada 18 519 0.9× 469 1.0× 76 0.7× 153 1.4× 221 2.2× 65 1.0k
Joannie Hui Hong Kong 16 328 0.6× 347 0.8× 84 0.7× 89 0.8× 92 0.9× 46 739
L.A.H. Monnens Netherlands 19 680 1.2× 313 0.7× 66 0.6× 156 1.4× 93 0.9× 49 1.2k
F. Labarthe France 17 502 0.9× 274 0.6× 58 0.5× 78 0.7× 309 3.1× 61 1.0k
Alberto Burlina Italy 13 395 0.7× 688 1.5× 253 2.2× 265 2.3× 190 1.9× 22 1.1k
Jean Rey France 20 585 1.0× 692 1.5× 100 0.9× 114 1.0× 237 2.4× 45 1.1k
Andrew A. M. Morris United Kingdom 22 903 1.6× 949 2.1× 82 0.7× 163 1.4× 257 2.6× 45 1.4k
Kwang‐Jen Hsiao Taiwan 18 478 0.9× 271 0.6× 42 0.4× 144 1.3× 111 1.1× 43 1.1k
Chloe Miu Mak China 17 337 0.6× 290 0.6× 71 0.6× 113 1.0× 94 0.9× 94 1000
Pablo Sanjurjo Spain 20 318 0.6× 420 0.9× 290 2.5× 237 2.1× 219 2.2× 67 1.1k

Countries citing papers authored by G. F. Hoffmann

Since Specialization
Citations

This map shows the geographic impact of G. F. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. F. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. F. Hoffmann more than expected).

Fields of papers citing papers by G. F. Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. F. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. F. Hoffmann. The network helps show where G. F. Hoffmann may publish in the future.

Co-authorship network of co-authors of G. F. Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of G. F. Hoffmann. A scholar is included among the top collaborators of G. F. Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. F. Hoffmann. G. F. Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhai, Yanhua, Liangyi Chen, Meike Hömme, et al.. (2010). Expression and function of matrix Gla protein in human peritoneal mesothelial cells. Nephrology Dialysis Transplantation. 25(10). 3213–3221. 5 indexed citations
2.
Herınger, Jana, Regina Ensenauer, Birgit Assmann, et al.. (2010). Use of guidelines improves the neurological outcome in glutaric aciduria type I. Neuropediatrics. 41(2). 9 indexed citations
3.
Bener, Abdülbari, et al.. (2009). High prevalence of vitamin D deficiency in young children in a highly sunny humid country: a global health problem.. PubMed. 61(1). 15–22. 103 indexed citations
4.
Hermanussen, Michael, et al.. (2009). Patterns of free amino acids in German convenience food products: marked mismatch between label information and composition. European Journal of Clinical Nutrition. 64(1). 88–98. 14 indexed citations
5.
Bağcı, Soyhan, Johannes Zschocke, G. F. Hoffmann, et al.. (2009). Pyridoxal phosphate-dependent neonatal epileptic encephalopathy. BMJ Case Reports. 2009. bcr1120081247–bcr1120081247. 6 indexed citations
6.
Hoffmann, G. F., et al.. (2008). MRSA-Prävalenz in medizinischen und pflegerischen Einrichtungen eines Landkreises. DMW - Deutsche Medizinische Wochenschrift. 133(19). 999–1003. 32 indexed citations
7.
Bağcı, Soyhan, Johannes Zschocke, G. F. Hoffmann, et al.. (2008). Pyridoxal phosphate-dependent neonatal epileptic encephalopathy. Archives of Disease in Childhood Fetal & Neonatal. 93(2). F151–F152. 45 indexed citations
8.
Abu‐Amero, Khaled K., et al.. (2007). LC‐MS/MS determination of dibasic amino acids for the diagnosis of cystinuria. Application in a family affected by a novel splice‐acceptor site mutation in the SLC7A9 gene. Journal of Inherited Metabolic Disease. 30(4). 611–611. 10 indexed citations
9.
Assmann, Birgit, Martina Baethmann, Ron A. Wevers, et al.. (2006). Clinical Findings and a Therapeutic Trial in the First Patient with β-Ureidopropionase Deficiency. Neuropediatrics. 37(1). 20–25. 12 indexed citations
10.
Burlina, Alessandro P., et al.. (2004). Management of movement disorders in glutaryl‐CoA dehydrogenase deficiency: Anticholinergic drugs and botulinum toxin as additional therapeutic options. Journal of Inherited Metabolic Disease. 27(6). 911–915. 17 indexed citations
11.
Hoffmann, G. F., et al.. (2001). Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning. Bone Marrow Transplantation. 28(1). 93–96. 16 indexed citations
12.
Witsch‐Baumgartner, Martina, Elżbieta Ciara, Jürgen Löffler, et al.. (2001). Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations. European Journal of Human Genetics. 9(1). 45–50. 53 indexed citations
13.
Zschocke, Johannes & G. F. Hoffmann. (2000). PAH gene mutation analysis in clinical practice – comments on mutation analysis anticipates dietary requirements in phenylketonuria. European Journal of Pediatrics. 159(S2). S154–S155. 6 indexed citations
14.
Zafeiriou, Dimitrios, et al.. (2000). Atypical and Variable Clinical Presentation of Glutaric Aciduria Type I. Neuropediatrics. 31(6). 303–306. 11 indexed citations
15.
Muntau, Ania C., Wulf Röschinger, Andreas Merkenschlager, et al.. (2000). Combined D-2- and L-2-Hydroxyglutaric Aciduria with Neonatal Onset Encephalopathy: A Third Biochemical Variant of 2-Hydroxyglutaric Aciduria?. Neuropediatrics. 31(3). 137–140. 40 indexed citations
16.
Wevers, Ron A., J.F. de Rijk-van Andel, Chad A. Brautigam, et al.. (1999). A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC). Journal of Inherited Metabolic Disease. 22(4). 364–373. 38 indexed citations
17.
Schwab, Stefan, et al.. (1999). Enzymdefekte des Harnstoffzyklus in der Differentialdiagnose der akuten Enzephalopathie im Erwachsenenalter. Der Nervenarzt. 70(2). 111–118. 7 indexed citations
18.
19.
Hoffmann, G. F., A Burlina, M. Durán, et al.. (1996). Clinical Course, Early Diagnosis, Treatment, and Prevention of Disease in Glutaryl-CoA Dehydrogenase Deficiency. Neuropediatrics. 27(3). 115–123. 160 indexed citations
20.
Hoffmann, G. F., et al.. (1989). [Changes in the pathobiochemical reactions in traumatic-hemorrhagic shock following therapy with blood substitutes based on perfluorocarbon].. PubMed. 30(1). 53–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilary Vallance Breakdown of academic impact, for papers by Joannie Hui Breakdown of academic impact, for papers by L.A.H. Monnens Breakdown of academic impact, for papers by F. Labarthe Breakdown of academic impact, for papers by Alberto Burlina Breakdown of academic impact, for papers by Jean Rey Breakdown of academic impact, for papers by Andrew A. M. Morris Breakdown of academic impact, for papers by Kwang‐Jen Hsiao Breakdown of academic impact, for papers by Chloe Miu Mak Breakdown of academic impact, for papers by Pablo Sanjurjo
Rankless by CCL
2026